TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/07/2026
Back to search
Official data from USPTO
AMTAGVI
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
24
Latest update
04/09/2026
Trademark type
Word
Nice classes
5, 44
Filing date
05/10/2023
Registration date
10/14/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/14/2025
Last transaction
04/09/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
11/22/2023
First use in commerce
11/22/2023
Drawing code
4
Owner type
03
Owner location
San Carlos, CA, US
Examiner
YAO, GRETTA
Law office
M90
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Iovance Biotherapeutics, Inc.
Representatives
Carla B. Oakley MORGAN, LEWIS & BOCKIUS LLP
Technical classification
Nice Classes
Class 5Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations and biological preparations for the treatment of immune system related and oncological diseases and disorders; biological diagnostic preparations for medical use
Class 44
Medical treatment of cancer via the modification of cells; medical servicesmedical services for the treatment of a wide range of diseases and medical conditions via the modification of cells; medical services in the field of immunotherapy treatments; medical diagnosis and treatment of immune system related diseases and disorders; medical servicesmedical services for the diagnosis and treatment of a wide range of diseases and medical conditions; providing medical information relating to oncology and immunotherapy treatment; providing medical information; medical consultations; isolationcollectionbanking of human biological tissue for immunotherapy
Publications
History of USPTO decisions and trademark events.
24 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/07/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/07/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
10/14/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
10/14/2025
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
09/23/2025
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
09/23/2025
SUPC
STATEMENT OF USE PROCESSING COMPLETE
08/29/2025
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
08/29/2025
IUAF
USE AMENDMENT FILED
04/14/2025
EISU
TEAS STATEMENT OF USE RECEIVED
04/14/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
10/29/2024
EX1G
SOU EXTENSION 1 GRANTED
10/29/2024
EXT1
SOU EXTENSION 1 FILED
10/29/2024
EEXT
SOU TEAS EXTENSION RECEIVED
10/29/2024
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
05/07/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/12/2024
PUBO
PUBLISHED FOR OPPOSITION
03/12/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/21/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/21/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/05/2024
DOCK
ASSIGNED TO EXAMINER
02/02/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/09/2023
NWAP
NEW APPLICATION ENTERED
05/13/2023
Continuous trademark protection
Get notified about every new filing that threatens AMTAGVI or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.